Greenwich Lifesciences Inc(GLSI)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

GLSI Greenwich Lifesciences Inc

交易中 12-11 14:23:26 EST

11.52

+1.41

+13.90%

最高11.62	最低10.16	成交量17.28万
今开10.16	昨收10.11	日振幅14.44%
总市值1.60亿	流通市值7,340万	总股本1,385万
成交额187.59万	换手率2.71%	流通股本637.45万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"GLSI","market":"US","secType":"STK","nameCN":"Greenwich Lifesciences Inc","latestPrice":11.515,"timestamp":1765480980762,"preClose":10.11,"halted":0,"volume":172824,"delay":0,"floatShares":6374500,"shares":13854539,"eps":-1.460569,"marketStatus":"交易中","change":1.405,"latestTime":"12-11 14:23:26 EST","open":10.16,"high":11.62,"low":10.16,"amount":1875902.3810160002,"amplitude":0.144411,"askPrice":11.59,"askSize":100,"bidPrice":11.32,"bidSize":20,"shortable":3,"etf":0,"ttmEps":-1.460569,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1765486800000},"marketStatusCode":2,"adr":0,"listingDate":1601006400000,"exchange":"NASDAQ","adjPreClose":10.11,"preHourTrading":{"tag":"盘前","latestPrice":10.01,"preClose":10.11,"latestTime":"09:15 EST","volume":862,"amount":8621.71969,"timestamp":1765462523756},"postHourTrading":{"tag":"盘后","latestPrice":10.15,"preClose":10.11,"latestTime":"19:47 EST","volume":1805,"amount":18351.087,"timestamp":1765414041377},"volumeRatio":2.828858},"requestUrl":"/m/hq/s/GLSI/tweets","defaultTab":"tweets","newsList":[{"id":"2576144706","title":"Greenwich Lifesciences, Inc.盘中异动 快速跳水5.03%报9.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2576144706","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576144706?lang=zh_cn&edition=full","pubTime":"2025-10-17 00:12","pubTimestamp":1760631160,"startTime":"0","endTime":"0","summary":"北京时间2025年10月17日00时12分，Greenwich Lifesciences, Inc.股票出现异动，股价大幅跳水5.03%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体涨幅为1.08%。Greenwich Lifesciences, Inc.公司简介：Greenwich LifeSciences Inc 是一家临床阶段的生物制药公司，专注于其 III 期临床试验 Flamingo-01，该试验正在评估 GLSI-100，是一种预防乳腺癌复发的免疫疗法。GP2 GM-CSF 的组合称为 GLSI-100。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251017001240a4638e1c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251017001240a4638e1c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GLSI","BK4139"],"gpt_icon":0},{"id":"2570531839","title":"Greenwich Lifesciences, Inc.盘中异动 股价大跌5.28%报9.87美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2570531839","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570531839?lang=zh_cn&edition=full","pubTime":"2025-09-26 21:55","pubTimestamp":1758894920,"startTime":"0","endTime":"0","summary":"北京时间2025年09月26日21时55分，Greenwich Lifesciences, Inc.股票出现异动，股价急速下挫5.28%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体涨幅为0.38%。Greenwich Lifesciences, Inc.公司简介：Greenwich LifeSciences Inc 是一家临床阶段的生物制药公司，专注于其 III 期临床试验 Flamingo-01，该试验正在评估 GLSI-100，是一种预防乳腺癌复发的免疫疗法。GP2 GM-CSF 的组合称为 GLSI-100。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092621552097abaf55&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092621552097abaf55&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GLSI"],"gpt_icon":0},{"id":"2567304102","title":"Greenwich Lifesciences, Inc.盘中异动 股价大涨5.16%报11.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2567304102","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567304102?lang=zh_cn&edition=full","pubTime":"2025-09-16 03:15","pubTimestamp":1757963747,"startTime":"0","endTime":"0","summary":"北京时间2025年09月16日03时15分，Greenwich Lifesciences, Inc.股票出现波动，股价大幅上涨5.16%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体涨幅为0.07%。Greenwich Lifesciences, Inc.公司简介：Greenwich LifeSciences Inc 是一家临床阶段的生物制药公司，专注于其 III 期临床试验 Flamingo-01，该试验正在评估 GLSI-100，是一种预防乳腺癌复发的免疫疗法。GP2 GM-CSF 的组合称为 GLSI-100。消息层面，截至03时15分，《Noble Financial维持Greenwich LifeSciences买入评级，维持目标价45美元》资讯为影响Greenwich Lifesciences, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025091603154897943470&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025091603154897943470&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GLSI"],"gpt_icon":0},{"id":"2566984850","title":"Greenwich Lifesciences, Inc.股价拉升10.00% 市值涨1649.26万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2566984850","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566984850?lang=zh_cn&edition=full","pubTime":"2025-09-10 21:33","pubTimestamp":1757511195,"startTime":"0","endTime":"0","summary":"北京时间2025年09月10日21时33分，Greenwich Lifesciences, Inc.股票出现异动，股价快速拉升10.00%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体跌幅为0.59%。Greenwich Lifesciences, Inc.公司简介：Greenwich LifeSciences Inc 是一家临床阶段的生物制药公司，专注于其 III 期临床试验 Flamingo-01，该试验正在评估 GLSI-100，是一种预防乳腺癌复发的免疫疗法。GP2 GM-CSF 的组合称为 GLSI-100。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250910213315a4c0e692&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250910213315a4c0e692&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4211","BK4139","GLSI","BK4082","SI"],"gpt_icon":0},{"id":"2557578267","title":"Greenwich Lifesciences, Inc.盘中异动 早盘股价大涨5.23%报12.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557578267","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557578267?lang=zh_cn&edition=full","pubTime":"2025-08-08 22:16","pubTimestamp":1754662588,"startTime":"0","endTime":"0","summary":"北京时间2025年08月08日22时16分，Greenwich Lifesciences, Inc.股票出现异动，股价快速拉升5.23%。截至发稿，该股报12.28美元/股，成交量2.2653万股，换手率0.17%，振幅2.40%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体跌幅为0.46%。Greenwich Lifesciences, Inc.公司简介：Greenwich LifeSciences Inc 是一家临床阶段的生物制药公司，专注于其 III 期临床试验 Flamingo-01，该试验正在评估 GLSI-100，是一种预防乳腺癌复发的免疫疗法。GP2 GM-CSF 的组合称为 GLSI-100。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808221629a47d6d23&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808221629a47d6d23&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GLSI","BK4139"],"gpt_icon":0},{"id":"2557335726","title":"Greenwich Lifesciences, Inc.盘中异动 快速上涨5.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557335726","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557335726?lang=zh_cn&edition=full","pubTime":"2025-08-05 02:22","pubTimestamp":1754331776,"startTime":"0","endTime":"0","summary":"北京时间2025年08月05日02时22分，Greenwich Lifesciences, Inc.股票出现波动，股价大幅拉升5.86%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体涨幅为1.40%。Greenwich Lifesciences, Inc.公司简介：Greenwich LifeSciences Inc 是一家临床阶段的生物制药公司，专注于其 III 期临床试验 Flamingo-01，该试验正在评估 GLSI-100，是一种预防乳腺癌复发的免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805022256973370bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805022256973370bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GLSI"],"gpt_icon":0},{"id":"2555029639","title":"Greenwich Lifesciences, Inc.盘中异动 下午盘股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555029639","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555029639?lang=zh_cn&edition=full","pubTime":"2025-07-31 02:32","pubTimestamp":1753900331,"startTime":"0","endTime":"0","summary":"北京时间2025年07月31日02时32分，Greenwich Lifesciences, Inc.股票出现波动，股价大幅拉升5.03%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体涨幅为0.81%。Greenwich Lifesciences, Inc.公司简介：Greenwich LifeSciences Inc 是一家临床阶段的生物制药公司，专注于其 III 期临床试验 Flamingo-01，该试验正在评估 GLSI-100，是一种预防乳腺癌复发的免疫疗法。GP2 GM-CSF 的组合称为 GLSI-100。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073102321294c468aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073102321294c468aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GLSI"],"gpt_icon":0},{"id":"2551296111","title":"Greenwich Lifesciences, Inc.盘中异动 早盘股价大涨5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551296111","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551296111?lang=zh_cn&edition=full","pubTime":"2025-07-16 23:05","pubTimestamp":1752678313,"startTime":"0","endTime":"0","summary":"北京时间2025年07月16日23时05分，Greenwich Lifesciences, Inc.股票出现异动，股价大幅拉升5.09%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体涨幅为1.25%。Greenwich Lifesciences, Inc.公司简介：Greenwich LifeSciences Inc 是一家临床阶段的生物制药公司，专注于其 III 期临床试验 Flamingo-01，该试验正在评估 GLSI-100，是一种预防乳腺癌复发的免疫疗法。GP2 GM-CSF 的组合称为 GLSI-100。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716230513a6adc699&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716230513a6adc699&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GLSI","BK4139"],"gpt_icon":0},{"id":"2551180882","title":"Greenwich Lifesciences, Inc.盘中异动 临近午盘快速下挫6.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551180882","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551180882?lang=zh_cn&edition=full","pubTime":"2025-07-14 23:47","pubTimestamp":1752508032,"startTime":"0","endTime":"0","summary":"北京时间2025年07月14日23时47分，Greenwich Lifesciences, Inc.股票出现异动，股价大幅跳水6.55%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体涨幅为1.08%。Greenwich Lifesciences, Inc.公司简介：Greenwich LifeSciences Inc 是一家临床阶段的生物制药公司，专注于其 III 期临床试验 Flamingo-01，该试验正在评估 GLSI-100，是一种预防乳腺癌复发的免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071423471295424a5c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071423471295424a5c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GLSI","BK4139"],"gpt_icon":0},{"id":"2550731066","title":"Greenwich Lifesciences, Inc.盘中异动 急速拉升5.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550731066","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550731066?lang=zh_cn&edition=full","pubTime":"2025-07-11 03:21","pubTimestamp":1752175281,"startTime":"0","endTime":"0","summary":"北京时间2025年07月11日03时21分，Greenwich Lifesciences, Inc.股票出现波动，股价大幅上涨5.40%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体涨幅为0.97%。Greenwich Lifesciences, Inc.公司简介：Greenwich LifeSciences Inc 是一家临床阶段的生物制药公司，专注于其 III 期临床试验 Flamingo-01，该试验正在评估 GLSI-100，是一种预防乳腺癌复发的免疫疗法。GP2 GM-CSF 的组合称为 GLSI-100。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711032121a44319fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711032121a44319fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GLSI"],"gpt_icon":0},{"id":"2548788672","title":"Greenwich Lifesciences, Inc.盘中异动 股价大涨5.84%报9.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548788672","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548788672?lang=zh_cn&edition=full","pubTime":"2025-07-02 00:18","pubTimestamp":1751386731,"startTime":"0","endTime":"0","summary":"北京时间2025年07月02日00时18分，Greenwich Lifesciences, Inc.股票出现异动，股价急速上涨5.84%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体涨幅为1.42%。Greenwich Lifesciences, Inc.公司简介：Greenwich LifeSciences Inc 是一家临床阶段的生物制药公司，专注于其 III 期临床试验 Flamingo-01，该试验正在评估 GLSI-100，是一种预防乳腺癌复发的免疫疗法。GP2 GM-CSF 的组合称为 GLSI-100。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507020018529532c416&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507020018529532c416&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GLSI"],"gpt_icon":0},{"id":"2518209140","title":"Greenwich Lifesciences, Inc.盘中异动 下午盘股价大跌5.04%报11.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518209140","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518209140?lang=zh_cn&edition=full","pubTime":"2025-03-11 02:37","pubTimestamp":1741631846,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日02时37分，Greenwich Lifesciences, Inc.股票出现波动，股价快速下挫5.04%。截至发稿，该股报11.49美元/股，成交量9322股，换手率0.07%，振幅5.21%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体涨幅为0.55%。Greenwich Lifesciences, Inc.公司简介：Greenwich lifessciences Inc 是一家临床阶段的生物制药公司，专注于开发 GP2，这是一种免疫疗法，用于预防已经接受过手术的患者乳腺癌复发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311023726964071c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311023726964071c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GLSI"],"gpt_icon":0},{"id":"2517535164","title":"Greenwich Lifesciences, Inc.盘中异动 快速下挫5.44%报11.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517535164","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517535164?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:49","pubTimestamp":1741272542,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时49分，Greenwich Lifesciences, Inc.股票出现波动，股价急速下挫5.44%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体跌幅为0.67%。Greenwich Lifesciences, Inc.公司简介：Greenwich lifessciences Inc 是一家临床阶段的生物制药公司，专注于开发 GP2，这是一种免疫疗法，用于预防已经接受过手术的患者乳腺癌复发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306224903abeb7cb7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306224903abeb7cb7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GLSI","BK4139"],"gpt_icon":0},{"id":"2516301329","title":"Greenwich Lifesciences, Inc.盘中异动 股价大涨5.29%报12.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516301329","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516301329?lang=zh_cn&edition=full","pubTime":"2025-03-01 04:53","pubTimestamp":1740775997,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日04时53分，Greenwich Lifesciences, Inc.股票出现波动，股价急速上涨5.29%。截至发稿，该股报12.15美元/股，成交量1.4511万股，换手率0.11%，振幅4.85%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体涨幅为0.79%。Greenwich Lifesciences, Inc.公司简介：Greenwich lifessciences Inc 是一家临床阶段的生物制药公司，专注于开发 GP2，这是一种免疫疗法，用于预防已经接受过手术的患者乳腺癌复发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503010453189896c7eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503010453189896c7eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GLSI","BK4139"],"gpt_icon":0},{"id":"2506306788","title":"Greenwich Lifesciences, Inc.盘中异动 早盘股价大涨5.04%报13.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506306788","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506306788?lang=zh_cn&edition=full","pubTime":"2025-01-27 23:24","pubTimestamp":1737991477,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日23时24分，Greenwich Lifesciences, Inc.股票出现异动，股价急速上涨5.04%。截至发稿，该股报13.75美元/股，成交量1.1902万股，换手率0.09%，振幅4.20%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体涨幅为1.32%。Greenwich Lifesciences, Inc.公司简介：Greenwich lifessciences Inc 是一家临床阶段的生物制药公司，专注于开发 GP2，这是一种免疫疗法，用于预防已经接受过手术的患者乳腺癌复发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127232437abba6aed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127232437abba6aed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GLSI"],"gpt_icon":0},{"id":"2505720299","title":"Greenwich Lifesciences, Inc.盘中异动 早盘股价大涨5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505720299","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505720299?lang=zh_cn&edition=full","pubTime":"2025-01-23 00:12","pubTimestamp":1737562326,"startTime":"0","endTime":"0","summary":"北京时间2025年01月23日00时12分，Greenwich Lifesciences, Inc.股票出现异动，股价大幅上涨5.26%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。Greenwich Lifesciences, Inc.公司简介：Greenwich lifessciences Inc 是一家临床阶段的生物制药公司，专注于开发 GP2，这是一种免疫疗法，用于预防已经接受过手术的患者乳腺癌复发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123001207a22bc844&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123001207a22bc844&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GLSI","BK4139"],"gpt_icon":0},{"id":"2505191202","title":"Greenwich Lifesciences, Inc.盘中异动 股价大跌5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505191202","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505191202?lang=zh_cn&edition=full","pubTime":"2025-01-22 02:03","pubTimestamp":1737482583,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日02时03分，Greenwich Lifesciences, Inc.股票出现波动，股价大幅下挫5.28%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体涨幅为2.22%。Greenwich Lifesciences, Inc.公司简介：Greenwich lifessciences Inc 是一家临床阶段的生物制药公司，专注于开发 GP2，这是一种免疫疗法，用于预防已经接受过手术的患者乳腺癌复发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122020303960bddc1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122020303960bddc1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GLSI","BK4139"],"gpt_icon":0},{"id":"2503477583","title":"Greenwich Lifesciences, Inc.盘中异动 早盘股价大跌7.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503477583","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503477583?lang=zh_cn&edition=full","pubTime":"2025-01-13 22:32","pubTimestamp":1736778726,"startTime":"0","endTime":"0","summary":"北京时间2025年01月13日22时32分，Greenwich Lifesciences, Inc.股票出现波动，股价急速下跌7.11%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体跌幅为0.89%。Greenwich Lifesciences, Inc.公司简介：Greenwich lifessciences Inc 是一家临床阶段的生物制药公司，专注于开发 GP2，这是一种免疫疗法，用于预防已经接受过手术的患者乳腺癌复发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113223206aba930af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113223206aba930af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GLSI"],"gpt_icon":0},{"id":"2502847893","title":"Greenwich Lifesciences, Inc.盘中异动 大幅下挫6.14%报12.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2502847893","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502847893?lang=zh_cn&edition=full","pubTime":"2025-01-10 23:19","pubTimestamp":1736522376,"startTime":"0","endTime":"0","summary":"北京时间2025年01月10日23时19分，Greenwich Lifesciences, Inc.股票出现异动，股价快速下挫6.14%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体跌幅为1.31%。Greenwich Lifesciences, Inc.公司简介：Greenwich lifessciences Inc 是一家临床阶段的生物制药公司，专注于开发 GP2，这是一种免疫疗法，用于预防已经接受过手术的患者乳腺癌复发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110231936a21d1a16&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110231936a21d1a16&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GLSI"],"gpt_icon":0},{"id":"2501779750","title":"Greenwich Lifesciences, Inc.盘中异动 急速下跌5.14%报13.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2501779750","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501779750?lang=zh_cn&edition=full","pubTime":"2025-01-08 23:20","pubTimestamp":1736349647,"startTime":"0","endTime":"0","summary":"北京时间2025年01月08日23时20分，Greenwich Lifesciences, Inc.股票出现异动，股价急速下跌5.14%。截至发稿，该股报13.10美元/股，成交量1.1805万股，换手率0.09%，振幅4.06%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体涨幅为0.18%。Greenwich Lifesciences, Inc.公司简介：Greenwich lifessciences Inc 是一家临床阶段的生物制药公司，专注于开发 GP2，这是一种免疫疗法，用于预防已经接受过手术的患者乳腺癌复发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108232047985f825f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108232047985f825f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GLSI","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.greenwichlifesciences.com","stockEarnings":[{"period":"1week","weight":0.2021},{"period":"1month","weight":0.1722},{"period":"3month","weight":-0.1147},{"period":"6month","weight":0.0989},{"period":"1year","weight":-0.2381},{"period":"ytd","weight":-0.0997}],"compareEarnings":[{"period":"1week","weight":0.0054},{"period":"1month","weight":0.009},{"period":"3month","weight":0.0455},{"period":"6month","weight":0.1517},{"period":"1year","weight":0.1406},{"period":"ytd","weight":0.1732}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Greenwich LifeSciences, Inc.成立于2006年8月29日，是特拉华州的一家公司。该公司是一家生物制药公司，正在开发GP2，这是一种旨在预防术后乳腺癌复发的免疫疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.013243},{"month":2,"riseRate":0.4,"avgChangeRate":0.00585},{"month":3,"riseRate":0.6,"avgChangeRate":0.079732},{"month":4,"riseRate":0.4,"avgChangeRate":-0.166968},{"month":5,"riseRate":0.4,"avgChangeRate":-0.034914},{"month":6,"riseRate":0.6,"avgChangeRate":0.055327},{"month":7,"riseRate":0.2,"avgChangeRate":-0.014519},{"month":8,"riseRate":0.6,"avgChangeRate":0.020316},{"month":9,"riseRate":0.2,"avgChangeRate":-0.041624},{"month":10,"riseRate":0,"avgChangeRate":-0.089083},{"month":11,"riseRate":0.666667,"avgChangeRate":0.225666},{"month":12,"riseRate":0.5,"avgChangeRate":0.931688}],"exchange":"NASDAQ","name":"Greenwich Lifesciences Inc","nameEN":"Greenwich Lifesciences Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Greenwich Lifesciences Inc(GLSI)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Greenwich Lifesciences Inc(GLSI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Greenwich Lifesciences Inc,GLSI,Greenwich Lifesciences Inc股票,Greenwich Lifesciences Inc股票老虎,Greenwich Lifesciences Inc股票老虎国际,Greenwich Lifesciences Inc行情,Greenwich Lifesciences Inc股票行情,Greenwich Lifesciences Inc股价,Greenwich Lifesciences Inc股市,Greenwich Lifesciences Inc股票价格,Greenwich Lifesciences Inc股票交易,Greenwich Lifesciences Inc股票购买,Greenwich Lifesciences Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Greenwich Lifesciences Inc(GLSI)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Greenwich Lifesciences Inc(GLSI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}